Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons

BACKGROUND: Generic substitution can have unintended consequences. In Germany, brand name to generic or generic to generic switching is mainly driven by rebate contracts. Frequent switching may raise concerns about bio- and therapeutic equivalence. Expected patient confusion may result in compromise...

Descripción completa

Detalles Bibliográficos
Autores principales: Gradl, Gabriele, Krieg, Eva-Maria, Schulz, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061522/
https://www.ncbi.nlm.nih.gov/pubmed/27785166
http://dx.doi.org/10.18549/PharmPract.2016.03.786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061522/
https://www.ncbi.nlm.nih.gov/pubmed/27785166
http://dx.doi.org/10.18549/PharmPract.2016.03.786

Ejemplares similares